DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL

CD4 CTL 的分化、抗病毒保护和致病作用

基本信息

  • 批准号:
    8655464
  • 负责人:
  • 金额:
    $ 44.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-07 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The study here sets out to define the conditions and factors involved in the in vivo and in vitro generation of CD4 cytotoxic T lymphocytes or CD4 CTL, in addition to determining the direct roles for CD4 CTL in vivo in antiviral immunity and immune-induced pathology. Many viruses establish persistent infections, which are mostly innocuous. However, immune control of these chronic viral infections has also been linked with viral-induced autoimmunity whereas in the absence of immune protection as in immune compromised individuals, reactivation of the viruses frequently causes lethal diseases. It is not known which immune cells keep persistent viruses under control or cause immune pathology, but cytolytic CD4 effector cells have been associated with chronic viral infections as well as with viral- induced autoimmunity. However, a direct role for CD4 CTL has not been determined and their specific contributions in health and disease remain unexplored. Recently, we published a study showing that CD4 CTL form a separate effector subset distinct from any CD4 T-helper subtype. We further determined that CD4 CTL are progeny of conventional na¿ve CD4 T cells that functionally reprogram in response to chronic antigen-stimulation such as chronic viral infections, and become MHC class II-restricted CTL. Using a combination of these profound new insights together with sophisticated gain- and loss-of-function approaches, we propose here to test the hypothesis that CD4 CTL play critical roles in controlling chronic viral infection and furthermore, that aberrant regulation of these cells might lead to viral-induced immune pathology and autoimmunity.
描述(由申请人提供):本研究旨在确定体内和体外产生CD4细胞毒性T淋巴细胞或CD4 CTL的条件和因素,以及确定体内CD4 CTL在抗病毒免疫和免疫诱导病理中的直接作用。许多病毒建立持续感染,这大多是无害的。然而,这些慢性病毒感染的免疫控制也与病毒诱导的自身免疫有关,而在缺乏免疫保护的情况下,如在免疫受损的个体中,病毒的再活化经常导致致命疾病。尚不清楚哪些免疫细胞使持久性病毒处于控制之下或引起免疫病理学,但溶细胞性CD4效应细胞与慢性病毒感染以及免疫性疾病相关。 病毒引起的自身免疫然而,CD4 CTL的直接作用尚未确定,它们在健康和疾病中的具体作用仍有待研究。最近,我们发表了一项研究表明,CD4 CTL形成一个独立的效应子亚群,不同于任何CD4辅助性T细胞亚型。我们进一步确定,CD4 CTL是传统的幼稚CD4 T细胞的后代,这些T细胞在慢性抗原刺激(如慢性病毒感染)的反应中进行功能性重编程,并成为MHC II类限制性CTL。使用这些深刻的新见解与复杂的增益和功能丧失的方法相结合,我们建议在这里测试的假设,CD4 CTL在控制慢性病毒感染中发挥关键作用,此外,这些细胞的异常调节可能会导致病毒诱导的免疫病理和自身免疫。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HILDE MC CHEROUTRE其他文献

HILDE MC CHEROUTRE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HILDE MC CHEROUTRE', 18)}}的其他基金

The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    10331846
  • 财政年份:
    2020
  • 资助金额:
    $ 44.25万
  • 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    9888243
  • 财政年份:
    2020
  • 资助金额:
    $ 44.25万
  • 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    10552636
  • 财政年份:
    2020
  • 资助金额:
    $ 44.25万
  • 项目类别:
Control of the Functional Fate of CD4 T Cells by LncRNA-Switch
LncRNA-Switch 对 CD4 T 细胞功能命运的控制
  • 批准号:
    9170246
  • 财政年份:
    2016
  • 资助金额:
    $ 44.25万
  • 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
  • 批准号:
    9246417
  • 财政年份:
    2014
  • 资助金额:
    $ 44.25万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8518428
  • 财政年份:
    2009
  • 资助金额:
    $ 44.25万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    7846264
  • 财政年份:
    2009
  • 资助金额:
    $ 44.25万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8134362
  • 财政年份:
    2009
  • 资助金额:
    $ 44.25万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    7939802
  • 财政年份:
    2009
  • 资助金额:
    $ 44.25万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8318169
  • 财政年份:
    2009
  • 资助金额:
    $ 44.25万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了